Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros

Banco de datos
Tipo de estudio
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Zhongguo Zhong Yao Za Zhi ; 44(23): 5191-5197, 2019 Dec.
Artículo en Zh | MEDLINE | ID: mdl-32237357

RESUMEN

This study aims to investigate the PPARγ agonists isolated from the aqueous extract of Siegesbeckia pubescens( SPA) and their anti-inflammatory activities in vitro. The 293 T cells transfected transiently with PPARγ recombinant plasmid were used as a screening model to guide the isolation of PPARγ activitating components,and then PPARγ activities were measured by double luciferase reporter gene assay. The chemical structures were identified by chromatography or spectroscopic techniques. Furthermore,a UC inflammatory model in vitro was established on HT-29 cells by stimulating with TNF-α. The mRNA levels and secretion of proinflammatory cytokines on HT-29 cells,such as IL-1ß,TNF-α,IL-8,were detected by RT-PCR and ELISA. The results showed that five diterpenoids were obtained from the fraction D_(50) with the strongest PPARγ activity among others in SPA,and determined as kirenol( 1),darutigenol( 2),enantiomeric-2-ketone-15,16,19-three hydroxypinomane-8( 14)-ene-19-O-ß-D-glucoside( 3),darutoside( 4),enantiomeric-2-ß,15,16,19-four hydroxypinomane-8( 14)-ene-19-O-ß-D-glucoside( 5),respectively. All the compounds exhibited active effects on PPARγ in a concentration-dependent manner( P<0. 01). In addition,compound 1 significantly inhibited the expression of IL-1ß mRNA and secretion of IL-8 on HT-29 cells inflammation model( P<0. 001); both compounds 2 and 3 effectively inhibited the expression of IL-1ß,TNF-α,IL-8 mRNA and secretion of IL-8( P<0. 01 or P<0. 001),although at different extent; compound 4 significantly inhibited the expression of IL-1ß and TNF-α mRNA( P<0. 01 or P<0. 001),while compound 5 inhibited the expression of IL-1ß mRNA obviously( P<0. 001). In conclusion,the diterpenoids 1-5 isolated from S. pubescens have the PPARγ activation activities and potential effects of anti-UC in vitro.


Asunto(s)
Antiinflamatorios/farmacología , Asteraceae/química , Diterpenos/farmacología , PPAR gamma/agonistas , Colitis Ulcerosa , Citocinas/inmunología , Células HT29 , Humanos , Factor de Necrosis Tumoral alfa
2.
Phys Chem Chem Phys ; 20(30): 19950-19957, 2018 Aug 01.
Artículo en Inglés | MEDLINE | ID: mdl-30022197

RESUMEN

Organic-inorganic hybrid perovskite (CH3NH3PbX3, X = Cl, Br, or I) quantum dots have become one of the most promising materials for optoelectronic applications. We controllably synthesized CH3NH3PbBr3 quantum dots with a tunable spectrum with the emission peaks covering the range from green (523.6 nm), blue and eventually to deep violet (409.4 nm), which is wider than that of quantum dots obtained without changing the halide component. The mechanism of the blueshift was investigated. The purified quantum dots have allowed the fabrication of efficient electroluminescence devices having a simple glass/ITO/PEDOT:PSS/TFB/CH3NH3PbBr3 quantum dot/TPBi/LiF/Al structure. CH3NH3PbBr3 quantum dots with 5-30 µL n-octylamine showed an ideal color-saturated green emission with Commission Internationale de l'Eclairage color coordinates of (0.123, 0.744) and a narrow full width at half-maximum of 19-24 nm. The photoluminescence quantum yield was up to 90.2%. In addition, it is also worth noting that the chromaticity coordinates (x, y) of CH3NH3PbBr3 quantum dots with 50-100 µL n-octylamine are (0.300, 0.344), (0.305, 0.314) and (0.323, 0.318) in the white region. All these properties indicate that these MAPbBr3 quantum dots can provide effective data support for the application of white LEDs, and may potentially be used as single-component multicolor-emitting materials, which can be applied to lighting and display technology.

3.
Nat Prod Commun ; 11(12): 1797-1800, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-30508336

RESUMEN

Two new 8, 14-seco skeleton C(21) steroidal aglycones, cynanbungeigenin A (1) and cynanbungeigenin B (2), were isolated from the hydrolyzed extract of the EtOAc soluble extract of the roots of Cynanchum bungei. Their structures were determined on the basis of chemical evidence and extensive spectroscopic methods, including 1D and 2D NMR spectroscopy.


Asunto(s)
Cynanchum/química , Pregnanos/aislamiento & purificación , Animales , Espectroscopía de Resonancia Magnética con Carbono-13 , Proteínas Hedgehog/antagonistas & inhibidores , Ratones , Células 3T3 NIH , Extractos Vegetales/química , Raíces de Plantas/química , Pregnanos/química , Pregnanos/farmacología , Espectroscopía de Protones por Resonancia Magnética
4.
Eur J Pharmacol ; 789: 370-384, 2016 Oct 15.
Artículo en Inglés | MEDLINE | ID: mdl-27448502

RESUMEN

Stephanthraniline A (STA), a C21 steroid isolated from Stephanotis mucronata (Blanco) Merr., was previously shown to inhibit T cells activation and proliferation in vitro and in vivo. The purpose of this study was to further evaluate the in vivo immunosuppressive activity of STA and to elucidate its potential mechanisms. The results showed that pretreatment with STA significantly attenuated concanavalin A (Con A)-induced hepatitis and reduced CD4(+) T cells activation and aggregation in hepatic tissue in mice. STA directly suppressed the activation and proliferation of Con A-induced CD4(+) T cells, and inhibited NFAT, NFκB and MAPK signaling cascades in activated CD4(+) T cells in vitro. Moreover, it was proved that STA inhibited T cells activation and proliferation through proximal T cell-receptor (TCR) signaling- and Ca(2+) signaling-independent way. The molecular docking studies predicted that STA could tight bind to PKCθ via five hydrogen. The further findings indicated STA directly inhibited PKCθ kinase activity, and its phosphorylation in activated CD4(+) T cells in vitro. Collectively, the present study indicated that STA could protect against CD4(+) T cell-mediated immunological hepatitis in mice through PKCθ and its downstream NFAT, NFκB and MAPK signaling cascades. These results highlight the potential of STA as an effective leading compound for use in the treatment of CD4(+) T cell-mediated inflammatory and autoimmune diseases.


Asunto(s)
Linfocitos T CD4-Positivos/efectos de los fármacos , Linfocitos T CD4-Positivos/inmunología , Diterpenos/farmacología , Hepatitis/tratamiento farmacológico , Hepatitis/inmunología , Isoenzimas/antagonistas & inhibidores , Activación de Linfocitos/efectos de los fármacos , Proteína Quinasa C/antagonistas & inhibidores , Animales , Señalización del Calcio/efectos de los fármacos , Dominio Catalítico , Agregación Celular/efectos de los fármacos , Proliferación Celular/efectos de los fármacos , Diterpenos/metabolismo , Diterpenos/uso terapéutico , Femenino , Hepatitis/metabolismo , Hepatitis/patología , Isoenzimas/química , Isoenzimas/metabolismo , Sistema de Señalización de MAP Quinasas/efectos de los fármacos , Ratones , Simulación del Acoplamiento Molecular , FN-kappa B/metabolismo , Factores de Transcripción NFATC/metabolismo , Fosforilación/efectos de los fármacos , Proteína Quinasa C/química , Proteína Quinasa C/metabolismo , Proteína Quinasa C-theta , Proteínas Quinasas/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA